Platinum-Resistant Recurrent Ovarian Cancer Last updated on Oct 10, 2026 Previous AURELIA Trial: Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer Next SOC-1: Secondary Cytoreduction in Platinum-Sensitive Relapsed Ovarian Cancer